Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 14,494 | 20,061 | 0 | 8,884 |
| Operating Income | -14,494 | -20,061 | N/A | -8,884 |
| Interest Expense | 249 | 0 | 0 | 0 |
| Other Income | 294 | 25 | 0 | 43 |
| Pre-tax Income | -14,449 | -20,036 | 0 | -8,841 |
| Income Tax | 33 | 23 | N/A | 8 |
| Net Income Continuous | -14,482 | -20,059 | N/A | -8,849 |
| Net Income | $-14,482 | $-20,059 | $N/A | $-8,849 |
| EPS Basic Total Ops | -0.38 | -0.52 | 0.00 | -0.24 |
| EPS Basic Continuous Ops | -0.38 | -0.52 | N/A | -0.24 |
| EPS Diluted Total Ops | -0.38 | -0.52 | 0.00 | -0.24 |
| EPS Diluted Continuous Ops | -0.38 | -0.52 | N/A | -0.24 |
| EBITDA(a) | $-14,489 | $-20,056 | $N/A | $-8,884 |